List of life sciences

Bay Area Life Science Industry Unites to Address Poverty and Social Inequities

Retrieved on: 
Thursday, October 20, 2022
Other Health, General Health, Professional Services, Pharmaceutical, Business, Other Education, DEI (Diversity, Equity and Inclusion), Primary, Secondary, Education, Biotechnology, Environmental, Social and Governance (ESG), Health, ALAS, Time, BioMarin Pharmaceutical, General Atlantic, Organization, General counsel, Poverty, Partnership, DEI, Gold, Kate Wilson, Industry, Board, CEO, JPMorgan Chase, State, Havas Creative, Bristol Myers Squibb, List of life sciences, Pharmaceutical industry, Genentech, Bronze, San Francisco Bay Area, Cytokinetics

George Scangos, Chairman of the Board for Life Science Cares Bay Area and CEO of Vir Bio, commented: I witnessed firsthand the impact that Life Science Cares had in Boston.

Key Points: 
  • George Scangos, Chairman of the Board for Life Science Cares Bay Area and CEO of Vir Bio, commented: I witnessed firsthand the impact that Life Science Cares had in Boston.
  • The Life Science Cares Bay Area 2022 Impact Festival will showcase a variety of regional nonprofit partners and service programs, and include updates from Life Science Cares own program Project Onramp , which matches students from underserved communities with paid summer internships at life science companies throughout the Bay Area.
  • Current Life Science Cares Bay Area corporate partners, nonprofit partners, event sponsors, and board members will receive complimentary entry.
  • Life Science Cares Bay Area, a 501(c)(3) nonprofit, is a collective effort to activate the financial and human capital of the life sciences industry and partner with nonprofits to disrupt the cycle of poverty and inequality in our communities.

Medical Device Innovation Consortium (MDIC) Partners with PerkinElmer's Horizon Discovery to Improve Accuracy of Next Generation Sequencing-Based Cancer Diagnostics

Retrieved on: 
Wednesday, October 19, 2022
Research, Medical Devices, Genetics, Health Technology, Biotechnology, Health, Pharmaceutical, Science, Oncology, Horizon Discovery, Method, National Institute, CDC, NIST, Efficiency, SRS, Grant, Gaps, National Institute of Standards and Technology, Patient, Catalog, Data, Contract, Research, NIH, PerkinElmer, Cancer, Senior, SRSS, Partnership, National Philanthropic Trust, Discovery, NGS, CEO, Safety, CRISPR, MDIC, Gordon, Initiative, DNA, FDA, List of life sciences, Medical device, Medicine, Pharmaceutical industry, Technology, Illumina, Quidel Corporation

The Medical Device Innovation Consortium ( MDIC ) has partnered with PerkinElmer's Horizon Discovery to develop and manufacture somatic reference samples (SRSs) to simplify and support validation of next generation sequencing (NGS)-based cancer diagnostics.

Key Points: 
  • The Medical Device Innovation Consortium ( MDIC ) has partnered with PerkinElmer's Horizon Discovery to develop and manufacture somatic reference samples (SRSs) to simplify and support validation of next generation sequencing (NGS)-based cancer diagnostics.
  • These tools could be used for diagnostic development, regulatory submissions, reimbursement decisions, and other applications across the total product life cycle of NGS-based diagnostics.
  • Leveraging its rich heritage in CRISPR editing technologies, Horizon Discovery has used this process to develop cell-based reference material for over a decade.
  • Founded in 2012, the Medical Device Innovation Consortium (MDIC) is the first public-private partnership created with the sole objective of advancing medical device regulatory science throughout the total product life cycle.

SPRINGBOARD ENTERPRISES RETURNS WITH ITS 14TH ANNUAL GALA CELEBRATING WOMEN ENTREPRENEURS

Retrieved on: 
Friday, October 21, 2022
The Ramble and Lake, New, Growth, Woman, Springboard, Multimedia, Technology, NEW, Pittsburgh Life Sciences Greenhouse, Invention, Entrepreneurship, List of life sciences, Interior design, Online shopping

NEW YORK, Oct. 21, 2022 /PRNewswire/ -- Springboard Enterprises, a women-founded and led growth accelerator, is proud to honor and celebrate twenty-two years of women entrepreneurs, inventors, and investors at its 14th annual gala on October 25th, 2022 at the historic Central Park Boathouse in New York City. After the pandemic-induced two-year hiatus, the gala dinner and cocktail hour reception is an opportunity for the Springboard team to recognize award recipients and honorees for their work supporting women-led businesses and fundraising for the organization.

Key Points: 
  • NEW YORK, Oct. 21, 2022 /PRNewswire/ -- Springboard Enterprises , a women-founded and led growth accelerator, is proud to honor and celebrate twenty-two years of women entrepreneurs, inventors, and investors at its 14th annual gala on October 25th, 2022 at the historic Central Park Boathouse in New York City.
  • "We have an extremely specific mission and it works," said Co-founder and Chairman of Springboard Enterprises Kay Koplovitz.
  • We look forward to celebrating these milestones at our annual gala."
  • The gala is returning with a prestigious guest list of women entrepreneurs and sponsors including William Blair , the New York Stock Exchange , and CVS Health Foundation .

AcuraBio Appoints Talented Senior Executives to Drive Global Growth Program

Retrieved on: 
Thursday, October 20, 2022
People, HR, Marketing, Therapy, Culture, Growth, Vaccine, DAF, Health, MBA, Joseph Fourier University, Multimedia, University, Graduate school, TGA, Industry, CDMO, CEO, Master's degree, IP, OGTR, University of Southern Queensland, First Peoples' Cultural Council, A-DNA, Head, Master, FDA, Biotechnology, List of life sciences, View, Management, Entrepreneurship, Engineering, Australians, Ampersand

AcuraBio brings two decades of experience in innovative therapeutics for customers in the biotech, pharmaceutical, and animal health industries.

Key Points: 
  • AcuraBio brings two decades of experience in innovative therapeutics for customers in the biotech, pharmaceutical, and animal health industries.
  • The CDMO provides recombinant proteins, vaccines, and complex live biotherapeutic products to customers on the leading edge in emerging therapeutics.
  • "AcuraBio will immediately benefit from Guillaume Herry's experience with companies in the US, Europe and Australia designing and implementing growth strategies."
  • Mr. Herry said: "I'm excited to be part of this new phase of growth and to be working with Glenn and the Ampersand team.

TECH FOR REFUGEES INITIATIVE AND FLEXPORT.ORG ARE EXPANDING PARTNERSHIP TO HELP REFUGEES IN UKRAINE, PAKISTAN, HORN OF AFRICA

Retrieved on: 
Thursday, October 20, 2022
Universe, Breakthrough Initiatives, Head, Life, Science, Organization, Refugee, Foundation, Carbon, Program, Emergency, Technology, Student, Goal, Breakthrough Prize, Horn, Interaction, Spotify, Food, Physics, Flexport, Yuri, Famine, COVID-19, Albert Einstein German Academic Refugee Initiative Fund, List of life sciences, Ambulance, Drug, Pharmaceutical industry, Renewable energy, Mathematics, Tech

SAN FRANCISCO, Oct. 20, 2022 /PRNewswire/ -- Tech for Refugees Initiative and Flexport.org today announced an expansion of their humanitarian efforts to help refugees, with an increase in current efforts to support refugees from the war in Ukraine, in addition to new funding for emergencies in Pakistan and the Horn of Africa.

Key Points: 
  • Organizations currently partnering with the initiative include Flexport.org , Airbnb.org , Spotify among others.
  • It uses the company's logistics platform and partnerships with trusted international aid organizations to deliver emergency medical equipment and other critical aid.
  • The program will deliver food to people displaced by famine both to aid refugees directlyand to those affectedto avoid becoming refugees.
  • "The refugee crises in Ukraine, as well as globally in places like Pakistan and East Africa, are impacting millions of people," said Yuri Milner, founder of Tech for Refugees.

TECH FOR REFUGEES INITIATIVE AND FLEXPORT.ORG ARE EXPANDING PARTNERSHIP TO HELP REFUGEES IN UKRAINE, PAKISTAN, HORN OF AFRICA

Retrieved on: 
Thursday, October 20, 2022
Universe, Breakthrough Initiatives, Head, Life, Science, Organization, Refugee, Foundation, Carbon, Program, Emergency, Technology, Student, Goal, Breakthrough Prize, Horn, Interaction, Spotify, Food, Physics, Flexport, Yuri, Famine, COVID-19, Albert Einstein German Academic Refugee Initiative Fund, List of life sciences, Ambulance, Drug, Pharmaceutical industry, Renewable energy, Mathematics, Tech

SAN FRANCISCO, Oct. 20, 2022 /PRNewswire/ -- Tech for Refugees Initiative and Flexport.org today announced an expansion of their humanitarian efforts to help refugees, with an increase in current efforts to support refugees from the war in Ukraine, in addition to new funding for emergencies in Pakistan and the Horn of Africa.

Key Points: 
  • Organizations currently partnering with the initiative include Flexport.org , Airbnb.org , Spotify among others.
  • It uses the company's logistics platform and partnerships with trusted international aid organizations to deliver emergency medical equipment and other critical aid.
  • The program will deliver food to people displaced by famine both to aid refugees directlyand to those affectedto avoid becoming refugees.
  • "The refugee crises in Ukraine, as well as globally in places like Pakistan and East Africa, are impacting millions of people," said Yuri Milner, founder of Tech for Refugees.

Endpoint Clinical Selects Egnyte to Enhance IRT Audit Logs for Clinical Trials

Retrieved on: 
Thursday, October 20, 2022
Cloud, List of life sciences, Organization, IRT, Industry, PULSE, DRIVE, Clinical trial, Solution, Compliance, Medical imaging, Audit, Quality, Egnyte, EU

WAKEFIELD, Mass. and MOUNTAIN VIEW, Calif., Oct. 20, 2022 /PRNewswire-PRWeb/ -- Endpoint Clinical, a leader in global interactive response technology (IRT®) for clinical trials, and Egnyte, the secure platform for content collaboration and governance, today announced that Endpoint Clinical has partnered with Egnyte, providing a Google Cloud-compliant platform to establish a secure file server that can share IRT audit logs directly with Investigators post study close.

Key Points: 
  • Endpoint Clinical partnered with Egnyte to provide a Google Cloud-compliant platform to establish a secure file server that can share IRT audit logs directly with Investigators post study close.
  • and MOUNTAIN VIEW, Calif., Oct. 20, 2022 /PRNewswire-PRWeb/ -- Endpoint Clinical , a leader in global interactive response technology (IRT) for clinical trials, and Egnyte , the secure platform for content collaboration and governance, today announced that Endpoint Clinical has partnered with Egnyte, providing a Google Cloud-compliant platform to establish a secure file server that can share IRT audit logs directly with Investigators post study close.
  • Working with Egnyte, Endpoint Clinical has created a validated system that extracts IRT audit log data for each site and directly provisions the data files to investigators in the secure GxP-compliant platform.
  • To learn more about how Endpoint Clinical has enhanced its IRT solution with Egnyte, visit http://www.endpointclinical.com/audit-data-management .

Coave Therapeutics Strengthens Board of Directors

Retrieved on: 
Thursday, October 20, 2022
National Institute, LinkedIn, Master of Science, Therapy, List of life sciences, Growth, General manager, Science, Neurodegeneration, Medical research, Biotechnology, Takeda Pharmaceutical Company, RNA interference, INSEAD, MBA, Research, The Advisory Board Company, Bachelor of Science, Senior, Eye, University, Company, Doctor of Philosophy, AAV, Industry, INSERM, Board, CEO, Portfolio strategy, Safety, ATyr Pharma, Management, Molecular biology, Consulate General of Israel to the Pacific Northwest Region, Board of directors, Director, International Management Institute, New Delhi, Genzyme, Central nervous system, Pharmaceutical industry, Vaccine, University of Paris, Astellas Pharma, Physics

PARIS, Oct. 20, 2022 /PRNewswire/ -- Coave Therapeutics ('Coave'), a biotech company leading the transition of genetic medicine from (ultra) rare to prevalent conditions in neurodegenerative diseases, today announces Frederic Chereau as Chairman of the Board and the appointment of Dr Claudia Mitchell, PhD, MBA to the Company's Board of Directors as an independent non-executive director.

Key Points: 
  • PARIS, Oct. 20, 2022 /PRNewswire/ -- Coave Therapeutics ('Coave'), a biotech company leading the transition of genetic medicine from (ultra) rare to prevalent conditions in neurodegenerative diseases, today announces Frederic Chereau as Chairman of the Board and the appointment of Dr Claudia Mitchell, PhD, MBA to the Company's Board of Directors as an independent non-executive director.
  • Dr Claudia Mitchell added: "I am delighted to be joining Coave's Board during this exciting period of growth for the Company.
  • The Coave Board of Directors is as follows:
    At Coave Therapeutics, we are leading the transition of genetic medicine from (ultra) rare to prevalent conditions, with an initial focus on neurodegenerative diseases.
  • Headquartered in Paris, France, Coave Therapeutics is backed by leading international life sciences investors.

Coave Therapeutics Strengthens Board of Directors

Retrieved on: 
Thursday, October 20, 2022
National Institute, LinkedIn, Master of Science, Therapy, List of life sciences, Growth, General manager, Science, Neurodegeneration, Medical research, Biotechnology, Takeda Pharmaceutical Company, RNA interference, INSEAD, MBA, Research, The Advisory Board Company, Bachelor of Science, Senior, Eye, University, Company, Doctor of Philosophy, AAV, Industry, INSERM, Board, CEO, Portfolio strategy, Safety, ATyr Pharma, Management, Molecular biology, Consulate General of Israel to the Pacific Northwest Region, Board of directors, Director, International Management Institute, New Delhi, Genzyme, Central nervous system, Pharmaceutical industry, Vaccine, University of Paris, Astellas Pharma, Physics

PARIS, Oct. 20, 2022 /PRNewswire/ -- Coave Therapeutics ('Coave'), a biotech company leading the transition of genetic medicine from (ultra) rare to prevalent conditions in neurodegenerative diseases, today announces Frederic Chereau as Chairman of the Board and the appointment of Dr Claudia Mitchell, PhD, MBA to the Company's Board of Directors as an independent non-executive director.

Key Points: 
  • PARIS, Oct. 20, 2022 /PRNewswire/ -- Coave Therapeutics ('Coave'), a biotech company leading the transition of genetic medicine from (ultra) rare to prevalent conditions in neurodegenerative diseases, today announces Frederic Chereau as Chairman of the Board and the appointment of Dr Claudia Mitchell, PhD, MBA to the Company's Board of Directors as an independent non-executive director.
  • Dr Claudia Mitchell added: "I am delighted to be joining Coave's Board during this exciting period of growth for the Company.
  • The Coave Board of Directors is as follows:
    At Coave Therapeutics, we are leading the transition of genetic medicine from (ultra) rare to prevalent conditions, with an initial focus on neurodegenerative diseases.
  • Headquartered in Paris, France, Coave Therapeutics is backed by leading international life sciences investors.

Introducing Papercurve 2.0

Retrieved on: 
Thursday, October 20, 2022
Contract lifecycle management, Time, Review, Workflow, Software as a service, MaRS Discovery District, Technology, AI, Customer success, CEO, List of life sciences, CTO, Solution, Compliance, Risk management

With the launch of Papercurve 2.0, the company becomes the new, multi-product standard for Life Sciences compliance and collaboration software.

Key Points: 
  • With the launch of Papercurve 2.0, the company becomes the new, multi-product standard for Life Sciences compliance and collaboration software.
  • TORONTO, Oct. 20, 2022 /PRNewswire/ - Papercurve today announced the launch of Papercurve 2.0, a new multi-product SaaS platform for Life Science companies.
  • Papercurve 2.0 is purpose-built for growing teams that need state of the art tools to create, review, monitor and share content in a secure and compliant way.
  • Papercurve has a full solution for content creation, collaboration and secure sharing that your team will actually use" says Ryan Whitham, CEO at Papercurve.